Cargando…

Knocking out the Vitamin D Receptor Enhances Malignancy and Decreases Responsiveness to Vitamin D3 Hydroxyderivatives in Human Melanoma Cells

SIMPLE SUMMARY: Active forms of vitamin D3, including 1,25(OH)(2)D3, 20(OH)D3 and 1,20(OH)(2)D3, inhibited cell proliferation, migration rate and the ability to form colonies and spheroids in the wild-type melanoma cell line, while cells with the vitamin D receptor (VDR) silenced showed an increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Podgorska, Ewa, Kim, Tae-Kang, Janjetovic, Zorica, Urbanska, Krystyna, Tuckey, Robert C., Bae, Sejong, Slominski, Andrzej T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269360/
https://www.ncbi.nlm.nih.gov/pubmed/34206371
http://dx.doi.org/10.3390/cancers13133111
_version_ 1783720561953734656
author Podgorska, Ewa
Kim, Tae-Kang
Janjetovic, Zorica
Urbanska, Krystyna
Tuckey, Robert C.
Bae, Sejong
Slominski, Andrzej T.
author_facet Podgorska, Ewa
Kim, Tae-Kang
Janjetovic, Zorica
Urbanska, Krystyna
Tuckey, Robert C.
Bae, Sejong
Slominski, Andrzej T.
author_sort Podgorska, Ewa
collection PubMed
description SIMPLE SUMMARY: Active forms of vitamin D3, including 1,25(OH)(2)D3, 20(OH)D3 and 1,20(OH)(2)D3, inhibited cell proliferation, migration rate and the ability to form colonies and spheroids in the wild-type melanoma cell line, while cells with the vitamin D receptor (VDR) silenced showed an increased but not complete resistance to their action. Furthermore, silencing of the VDR in melanoma cells enhanced their proliferation as well as spheroid and colony formation and increased their migration rate. Previous clinicopathological studies have shown an inverse correlation between VDR expression, melanoma progression and poor outcome of the disease. Thus, the expression of VDR is not only necessary for the inhibition of melanoma growth by active forms of vitamin D, but the VDR can also function as a melanoma tumor suppressor gene. ABSTRACT: Vitamin D3 is not only involved in calcium and phosphate metabolism in humans, but it can also affect proliferation and differentiation of normal and cancer cells, including melanoma. The mechanism of the anti-cancer action of vitamin D3 is not fully understood. The nuclear vitamin D receptor (VDR) is crucial for the phenotypic effects of vitamin D hydroxyderivatives. VDR expression shows an inverse correlation with melanoma progression and poor outcome of the disease. In this study we knocked out the VDR in a human melanoma cell line using CRISPR methodology. This enhanced the proliferation of melanoma cells grown in monolayer culture, spheroids or colonies and their migration. Activated forms of vitamin D, including classical 1,25(OH)(2)D3, 20(OH)D3 and 1,20(OH)(2)D3, inhibited cell proliferation, migration rate and the ability to form colonies and spheroids in the wild-type melanoma cell line, while VDR KO cells showed a degree of resistance to their action. These results indicate that expression of VDR is important for the inhibition of melanoma growth induced by activated forms of vitamin D. In conclusion, based on our previous clinicopathological analyses and the current study, we suggest that the VDR can function as a melanoma tumor suppressor gene.
format Online
Article
Text
id pubmed-8269360
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82693602021-07-10 Knocking out the Vitamin D Receptor Enhances Malignancy and Decreases Responsiveness to Vitamin D3 Hydroxyderivatives in Human Melanoma Cells Podgorska, Ewa Kim, Tae-Kang Janjetovic, Zorica Urbanska, Krystyna Tuckey, Robert C. Bae, Sejong Slominski, Andrzej T. Cancers (Basel) Article SIMPLE SUMMARY: Active forms of vitamin D3, including 1,25(OH)(2)D3, 20(OH)D3 and 1,20(OH)(2)D3, inhibited cell proliferation, migration rate and the ability to form colonies and spheroids in the wild-type melanoma cell line, while cells with the vitamin D receptor (VDR) silenced showed an increased but not complete resistance to their action. Furthermore, silencing of the VDR in melanoma cells enhanced their proliferation as well as spheroid and colony formation and increased their migration rate. Previous clinicopathological studies have shown an inverse correlation between VDR expression, melanoma progression and poor outcome of the disease. Thus, the expression of VDR is not only necessary for the inhibition of melanoma growth by active forms of vitamin D, but the VDR can also function as a melanoma tumor suppressor gene. ABSTRACT: Vitamin D3 is not only involved in calcium and phosphate metabolism in humans, but it can also affect proliferation and differentiation of normal and cancer cells, including melanoma. The mechanism of the anti-cancer action of vitamin D3 is not fully understood. The nuclear vitamin D receptor (VDR) is crucial for the phenotypic effects of vitamin D hydroxyderivatives. VDR expression shows an inverse correlation with melanoma progression and poor outcome of the disease. In this study we knocked out the VDR in a human melanoma cell line using CRISPR methodology. This enhanced the proliferation of melanoma cells grown in monolayer culture, spheroids or colonies and their migration. Activated forms of vitamin D, including classical 1,25(OH)(2)D3, 20(OH)D3 and 1,20(OH)(2)D3, inhibited cell proliferation, migration rate and the ability to form colonies and spheroids in the wild-type melanoma cell line, while VDR KO cells showed a degree of resistance to their action. These results indicate that expression of VDR is important for the inhibition of melanoma growth induced by activated forms of vitamin D. In conclusion, based on our previous clinicopathological analyses and the current study, we suggest that the VDR can function as a melanoma tumor suppressor gene. MDPI 2021-06-22 /pmc/articles/PMC8269360/ /pubmed/34206371 http://dx.doi.org/10.3390/cancers13133111 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Podgorska, Ewa
Kim, Tae-Kang
Janjetovic, Zorica
Urbanska, Krystyna
Tuckey, Robert C.
Bae, Sejong
Slominski, Andrzej T.
Knocking out the Vitamin D Receptor Enhances Malignancy and Decreases Responsiveness to Vitamin D3 Hydroxyderivatives in Human Melanoma Cells
title Knocking out the Vitamin D Receptor Enhances Malignancy and Decreases Responsiveness to Vitamin D3 Hydroxyderivatives in Human Melanoma Cells
title_full Knocking out the Vitamin D Receptor Enhances Malignancy and Decreases Responsiveness to Vitamin D3 Hydroxyderivatives in Human Melanoma Cells
title_fullStr Knocking out the Vitamin D Receptor Enhances Malignancy and Decreases Responsiveness to Vitamin D3 Hydroxyderivatives in Human Melanoma Cells
title_full_unstemmed Knocking out the Vitamin D Receptor Enhances Malignancy and Decreases Responsiveness to Vitamin D3 Hydroxyderivatives in Human Melanoma Cells
title_short Knocking out the Vitamin D Receptor Enhances Malignancy and Decreases Responsiveness to Vitamin D3 Hydroxyderivatives in Human Melanoma Cells
title_sort knocking out the vitamin d receptor enhances malignancy and decreases responsiveness to vitamin d3 hydroxyderivatives in human melanoma cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269360/
https://www.ncbi.nlm.nih.gov/pubmed/34206371
http://dx.doi.org/10.3390/cancers13133111
work_keys_str_mv AT podgorskaewa knockingoutthevitamindreceptorenhancesmalignancyanddecreasesresponsivenesstovitamind3hydroxyderivativesinhumanmelanomacells
AT kimtaekang knockingoutthevitamindreceptorenhancesmalignancyanddecreasesresponsivenesstovitamind3hydroxyderivativesinhumanmelanomacells
AT janjetoviczorica knockingoutthevitamindreceptorenhancesmalignancyanddecreasesresponsivenesstovitamind3hydroxyderivativesinhumanmelanomacells
AT urbanskakrystyna knockingoutthevitamindreceptorenhancesmalignancyanddecreasesresponsivenesstovitamind3hydroxyderivativesinhumanmelanomacells
AT tuckeyrobertc knockingoutthevitamindreceptorenhancesmalignancyanddecreasesresponsivenesstovitamind3hydroxyderivativesinhumanmelanomacells
AT baesejong knockingoutthevitamindreceptorenhancesmalignancyanddecreasesresponsivenesstovitamind3hydroxyderivativesinhumanmelanomacells
AT slominskiandrzejt knockingoutthevitamindreceptorenhancesmalignancyanddecreasesresponsivenesstovitamind3hydroxyderivativesinhumanmelanomacells